Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-26 Sale | 2022-10-28 6:56 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 10,000 | $40 | $400,000 | 353,370 (Indirect Direct) | View |
| 2022-10-11 Sale | 2022-10-13 4:57 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 5,000 | $25.5 | $127,500 | 363,370 (Indirect Direct) | View |
| 2022-09-06 Sale | 2022-09-07 4:37 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 5,000 | $26.58 | $132,892 | 368,370 (Indirect Direct) | View |
| 2022-08-04 Sale | 2022-08-05 7:12 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 15,000 | $25.57 | $383,508 | 373,889 (Indirect Direct) | View |
| 2022-05-20 Sale | 2022-05-24 4:32 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,112 | $25.5 | $104,856 | 388,889 (Indirect Direct) | View |
| 2022-05-05 Sale | 2022-05-09 4:35 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 888 | $25.8 | $22,914 | 391,968 (Indirect Direct) | View |
| 2022-04-05 Sale | 2022-04-07 5:24 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 5,000 | $25.59 | $127,950 | 392,856 (Indirect Direct) | View |
| 2022-03-11 Sale | 2022-03-15 9:09 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 10,000 | $25.5 | $255,000 | 397,856 (Indirect Direct) | View |
| 2021-12-27 Sale | 2021-12-28 4:15 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $23.6 | $112,092 | 450,732 (Indirect Direct) | View |
| 2021-12-16 Sale | 2021-12-20 4:35 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,619 | $22.5 | $103,928 | 455,482 (Indirect Direct) | View |
| 2021-12-09 Sale | 2021-12-13 5:20 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 131 | $22.5 | $2,948 | 460,101 (Indirect Direct) | View |
| 2021-10-26 Sale | 2021-10-28 6:00 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $22.69 | $107,778 | 459,216 (Indirect Direct) | View |
| 2021-09-27 Sale | 2021-09-29 7:52 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $26.17 | $124,303 | 463,966 (Indirect Direct) | View |
| 2021-08-26 Sale | 2021-08-30 6:06 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $25.38 | $120,543 | 468,716 (Indirect Direct) | View |
| 2021-07-26 Sale | 2021-07-28 4:32 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $22.7 | $107,825 | 473,466 (Indirect Direct) | View |
| 2021-06-28 Sale | 2021-06-30 5:41 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $24.37 | $115,770 | 478,216 (Indirect Direct) | View |
| 2021-06-07 Sale | 2021-06-09 4:53 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 9,500 | $22.5 | $213,750 | 482,966 (Indirect Direct) | View |
| 2021-03-26 Sale | 2021-03-29 7:18 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $23.88 | $113,433 | 399,894 (Indirect Direct) | View |
| 2021-02-26 Sale | 2021-03-02 5:37 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $23.93 | $113,663 | 404,644 (Indirect Direct) | View |
| 2021-01-26 Sale | 2021-01-28 4:36 pm | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $25.27 | $120,015 | 409,394 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-30 Option Award | 2023-01-04 4:33 pm | N/A 2032-12-30 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 15,000 | $0 | 369,054 (Direct) | View |
| 2022-09-02 Tax Withholding | 2022-09-07 4:37 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 519 | $26.38 | 368,370 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 8:56 pm | N/A 2032-03-01 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 39,000 | $0 | 440,856 (Direct) | View |
| 2021-12-20 Exercise | 2022-02-08 5:27 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,469 | $1.79 | 455,482 (Direct) | View |
| 2021-12-20 Exercise | 2022-02-08 5:27 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,469 | $0 | 455,482 (Direct) | View |
| 2021-12-27 Exercise | 2021-12-28 4:15 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $1.79 | 450,732 (Direct) | View |
| 2021-12-27 Exercise | 2021-12-28 4:15 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 450,732 (Direct) | View |
| 2021-12-16 Exercise | 2021-12-20 4:35 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,619 | $1.79 | 455,482 (Direct) | View |
| 2021-12-16 Exercise | 2021-12-20 4:35 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,619 | $0 | 455,482 (Direct) | View |
| 2021-12-09 Exercise | 2021-12-13 5:20 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 131 | $1.79 | 460,101 (Direct) | View |
| 2021-12-09 Exercise | 2021-12-13 5:20 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 131 | $0 | 460,101 (Direct) | View |
| 2021-10-26 Exercise | 2021-10-28 6:00 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $1.79 | 459,216 (Direct) | View |
| 2021-10-26 Exercise | 2021-10-28 6:00 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 459,216 (Direct) | View |
| 2021-09-27 Exercise | 2021-09-29 7:52 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $1.79 | 463,966 (Direct) | View |
| 2021-09-27 Exercise | 2021-09-29 7:52 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 463,966 (Direct) | View |
| 2021-08-26 Exercise | 2021-08-30 6:06 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $1.79 | 468,716 (Direct) | View |
| 2021-08-26 Exercise | 2021-08-30 6:06 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 468,716 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-28 4:32 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $1.79 | 473,466 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-28 4:32 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 473,466 (Direct) | View |
| 2021-06-28 Exercise | 2021-06-30 5:41 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $1.79 | 478,216 (Direct) | View |
| 2021-06-28 Exercise | 2021-06-30 5:41 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 478,216 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:53 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 2,241 | $1.79 | 482,966 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:53 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 7,259 | $0.04 | 482,966 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:53 pm | N/A 2025-04-23 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 9,500 | $0 | 482,966 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-23 7:31 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 2,793 | $1.79 | 484,264 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-23 7:31 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 2,793 | $0 | 484,264 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-06 8:10 pm | N/A 2031-03-31 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-26 Exercise | 2021-03-29 7:18 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0.04 | 399,894 (Direct) | View |
| 2021-03-26 Exercise | 2021-03-29 7:18 pm | N/A 2025-04-23 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 399,894 (Direct) | View |
| 2021-02-26 Exercise | 2021-03-02 5:37 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0.04 | 404,644 (Direct) | View |
| 2021-02-26 Exercise | 2021-03-02 5:37 pm | N/A 2025-04-23 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 404,644 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-28 4:36 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0.04 | 409,394 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-28 4:36 pm | N/A 2025-04-23 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 4,750 | $0 | 409,394 (Direct) | View |
| 2020-12-29 Exercise | 2020-12-30 8:26 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 740 | $1.79 | 484,264 (Direct) | View |
| 2020-12-29 Exercise | 2020-12-30 8:26 pm | N/A 2027-05-17 | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 740 | $0 | 484,264 (Direct) | View |
Ownership | 2020-06-11 7:44 pm | N/A N/A | Vaxcyte Inc. | PCVX | Fairman Jeff VP, Research | 0 | $0 | 668,113 (Direct) | View |